Ryan Zimmerman
Stock Analyst at BTIG
(4.53)
# 235
Out of 4,754 analysts
174
Total ratings
59.46%
Success rate
16.42%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $87 → $91 | $78.07 | +16.56% | 11 | Dec 12, 2024 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $51.14 | +29.06% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $283.62 | -4.80% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $112.21 | +32.79% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $557.96 | +0.54% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $389.92 | +1.05% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $3.20 | +212.50% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $92.59 | +14.48% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $21.91 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $103.99 | +21.17% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $84.31 | +18.61% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $78.99 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $26.86 | +171.78% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.75 | +198.59% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.45 | +566.67% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.84 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.76 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.56 | +156.41% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $5.04 | +19.05% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.03 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $22.89 | +127.17% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.01 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $14.03 | +99.57% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $183.46 | +9.02% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $269.57 | +29.84% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $137.58 | -5.51% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $64.98 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $93.03 | +37.59% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.99 | +7.22% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $62.30 | +46.07% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.32 | +157.35% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $14.93 | +251.64% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.62 | - | 3 | Apr 2, 2020 |
Globus Medical
Dec 12, 2024
Maintains: Buy
Price Target: $87 → $91
Current: $78.07
Upside: +16.56%
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $51.14
Upside: +29.06%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $283.62
Upside: -4.80%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $112.21
Upside: +32.79%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $557.96
Upside: +0.54%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $389.92
Upside: +1.05%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $3.20
Upside: +212.50%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $92.59
Upside: +14.48%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $21.91
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $103.99
Upside: +21.17%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $84.31
Upside: +18.61%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $78.99
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $26.86
Upside: +171.78%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.75
Upside: +198.59%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.45
Upside: +566.67%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.84
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.76
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.56
Upside: +156.41%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $5.04
Upside: +19.05%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $10.03
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $22.89
Upside: +127.17%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $17.01
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $14.03
Upside: +99.57%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $183.46
Upside: +9.02%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $269.57
Upside: +29.84%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $137.58
Upside: -5.51%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $64.98
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $93.03
Upside: +37.59%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $13.99
Upside: +7.22%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $62.30
Upside: +46.07%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $16.32
Upside: +157.35%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $14.93
Upside: +251.64%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $18.62
Upside: -